Search
for
Sort by
Research 841–870 of 1000+
- Pharmacology of anabolic steroids
- PERICARDIAL EFFUSIONS ASSOCIATED WITH MINOXIDIL
- Prevention of Chemotherapy-Induced Alopecia in Rats by CDK Inhibitors
- Chemoprevention of smoke-induced alopecia in mice by oral administration of l-cystine and vitamin B6
- Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer
- Alopecia After Switch to Tenofovir Alafenamide in 6 African American Women
- Periungual lesions secondary to chemotherapy with docetaxel
- Use of chemotherapy during human pregnancy
- Dermatological adverse events with taxane chemotherapy
- Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy
- Cutaneous reactions to recombinant cytokine therapy
- Hair Loss After Routine Immunizations
- Cutaneous lupus erythematosus
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- Hair Loss Pattern due to Chemotherapy-Induced Anagen Effluvium: A Cross-Sectional Observation
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- Alopecia With Endocrine Therapies in Patients With Cancer
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Update on the dermatologic use of systemic glucocorticosteroids
- Hair Growth‐Promoting Effect of <i>Carthamus tinctorius</i> Floret Extract
- Redefining hormone resistance in prostate cancer
- The transdermal inhibition of melanogenesis by a cell-membrane-permeable peptide delivery system based on poly-arginine
- Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- The Clinical Presentation of Systemic Lupus Erythematosus
- Immune modulation of hair follicle regeneration
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- INTERFERONS IN DERMATOLOGY
- Inhibitors of 5α -Reductase Type I in LNCaP Cells from the Roots of Angelica koreana